Susquehanna International Group, LLP Avalo Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

  • $568 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$3.0 - $10.45 $44,289 - $154,273
-14,763 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$7.57 - $21.72 $90,764 - $260,422
-11,990 Reduced 44.82%
14,763 $11,000
Q4 2021

Feb 14, 2022
BUY
$19.68 - $28.68 $108,869 - $158,657
5,532 Added 26.07%
26,753 $45,000
Q3 2021

Nov 15, 2021
BUY
$26.16 - $40.68 $555,141 - $863,270
21,221 New
21,221 $46,000

Others Institutions Holding AVTX

# of Institutions
1
Shares Held
34.6K
Call Options Held
0
Put Options Held
0
View Full List

About Avalo Therapeutics, Inc.

AVTX Quotes by TradingView
  • Ticker AVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,414,100
  • Market Cap $118M
  • Description
  • Avalo Therapeutics, Inc., a clinical-stage precision medicine company, discovers, develops, and commercializes targeted therapeutics for patients with unmet clinical need in immunology, immuno-oncology, and rare genetic diseases. It develops AVTX-002, a fully human anti-LIGHT monoclonal antibody, which is under Phase II clinical trial for the tr...
More about AVTX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email